🇺🇸 FDA
Pipeline program

Sodium Chloride Fresenius Kabi Italia 0.9 % Solution for infusion , DENOSUMAB, Sodium Fluoride (18F) Life Radiopharma 0,1 - 4 GBq/ml solution injectable

Approved small_molecule active

Quick answer

Sodium Chloride Fresenius Kabi Italia 0.9 % Solution for infusion , DENOSUMAB, Sodium Fluoride (18F) Life Radiopharma 0,1 - 4 GBq/ml solution injectable for Fibrous dysplasia/McCune-Albright syndrome is a Approved program (small_molecule) at Disc Medicine with 1 ClinicalTrials.gov record(s).

Program details

Company
Disc Medicine
Indication
Fibrous dysplasia/McCune-Albright syndrome
Phase
Approved
Modality
small_molecule
Status
active

Clinical trials